ArticleJournal of surgical case reports2026
Laser-based treatment of chronic anal fissures: a report of two cases.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic anal fissures (CAF) are painful and often resistant to medical therapy. While lateral internal sphincterotomy is effective, it carries a risk of incontinence. Laser Fissuroplasty (LaFiP) is a minimally invasive alternative gaining traction globally. We report two male patients aged 28 and 47 years, respectively, with CAF unresponsive to medical therapy. Both presented with severe post-defecation anal pain and were diagnosed with posterior midline fissures. LaFiP was performed under pudendal block using 350-400 joules of energy from a 1470 nm diode laser. Postoperatively, both experienced rapid symptom resolution and complete healing within weeks, with no incontinence at 6-month follow-up. LaFiP appears to be a safe and effective technique for managing CAF, particularly suitable for patients at risk of incontinence. Although limited by a short follow-up of six months, initial results from these two cases were promising. Nonetheless, the long-term durability of the intervention requires further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.